All In MedTech

Device Trial Radar · NCT07761598

The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.

Last checked: Nov 20, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Aug 2026

Primary completion

Dec 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Jacobs instituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University at Buffalo
First posted
Aug 12, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) is a prospective, single-arm investigation.

Conditions

  • Aneurysm Cerebral

Interventions

  • Fred X Medical Device Intervention for Aneurysm Treatment with DAPT Therapy.Device

    medial device intervention for aneurysm cerebral.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. A thromboembolic event in the territory supplied by the treated artery.Time frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Jacobs Institute

    Buffalo, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.